Logo image of ALUCI.PA

LUCIBEL SA (ALUCI.PA) Stock Fundamental Analysis

EPA:ALUCI - Euronext Paris - Matif - FR0011884378 - Common Stock - Currency: EUR

0.095  +0.01 (+5.56%)

Fundamental Rating

2

Taking everything into account, ALUCI scores 2 out of 10 in our fundamental rating. ALUCI was compared to 60 industry peers in the Electrical Equipment industry. ALUCI has a bad profitability rating. Also its financial health evaluation is rather negative. ALUCI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ALUCI has reported negative net income.
In the past year ALUCI has reported a negative cash flow from operations.
ALUCI had negative earnings in 4 of the past 5 years.
In the past 5 years ALUCI reported 4 times negative operating cash flow.
ALUCI.PA Yearly Net Income VS EBIT VS OCF VS FCFALUCI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

With a Return On Assets value of 0.72%, ALUCI perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
ALUCI has a better Return On Equity (7.58%) than 65.00% of its industry peers.
With a Return On Invested Capital value of 2.63%, ALUCI perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA 0.72%
ROE 7.58%
ROIC 2.63%
ROA(3y)-17.28%
ROA(5y)-32.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALUCI.PA Yearly ROA, ROE, ROICALUCI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300

1.3 Margins

With a Profit Margin value of 0.81%, ALUCI perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
ALUCI's Operating Margin of 1.48% is in line compared to the rest of the industry. ALUCI outperforms 45.00% of its industry peers.
ALUCI's Gross Margin of 64.39% is amongst the best of the industry. ALUCI outperforms 90.00% of its industry peers.
ALUCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.48%
PM (TTM) 0.81%
GM 64.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.76%
GM growth 5Y2.09%
ALUCI.PA Yearly Profit, Operating, Gross MarginsALUCI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

0

2. Health

2.1 Basic Checks

ALUCI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ALUCI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALUCI has more shares outstanding
ALUCI has a better debt/assets ratio than last year.
ALUCI.PA Yearly Shares OutstandingALUCI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
ALUCI.PA Yearly Total Debt VS Total AssetsALUCI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that ALUCI is in the distress zone and has some risk of bankruptcy.
ALUCI has a worse Altman-Z score (0.37) than 78.33% of its industry peers.
ALUCI has a Debt/Equity ratio of 2.28. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.28, ALUCI is doing worse than 88.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.28
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACC0.37
WACC7.16%
ALUCI.PA Yearly LT Debt VS Equity VS FCFALUCI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.90 indicates that ALUCI may have some problems paying its short term obligations.
With a Current ratio value of 0.90, ALUCI is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
ALUCI has a Quick Ratio of 0.90. This is a bad value and indicates that ALUCI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.47, ALUCI is not doing good in the industry: 95.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.47
ALUCI.PA Yearly Current Assets VS Current LiabilitesALUCI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

ALUCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.25%, which is quite impressive.
Looking at the last year, ALUCI shows a quite strong growth in Revenue. The Revenue has grown by 10.49% in the last year.
Measured over the past years, ALUCI shows a small growth in Revenue. The Revenue has been growing by 2.24% on average per year.
EPS 1Y (TTM)102.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-665.62%
Revenue 1Y (TTM)10.49%
Revenue growth 3Y-3.96%
Revenue growth 5Y2.24%
Sales Q2Q%-37.28%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALUCI.PA Yearly Revenue VS EstimatesALUCI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B 25B
ALUCI.PA Yearly EPS VS EstimatesALUCI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ALUCI.PA Price Earnings VS Forward Price EarningsALUCI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALUCI.PA Per share dataALUCI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALUCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUCIBEL SA

EPA:ALUCI (8/7/2025, 7:00:00 PM)

0.095

+0.01 (+5.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)04-23 2024-04-23
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.62%
Ins Owner ChangeN/A
Market Cap3.17M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B 3.29
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.27
BVpS0.03
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.72%
ROE 7.58%
ROCE 3.61%
ROIC 2.63%
ROICexc 3.5%
ROICexgc N/A
OM 1.48%
PM (TTM) 0.81%
GM 64.39%
FCFM N/A
ROA(3y)-17.28%
ROA(5y)-32.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.76%
GM growth 5Y2.09%
F-Score5
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 2.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 9.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.47
Altman-Z 0.37
F-Score5
WACC7.16%
ROIC/WACC0.37
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)6.54%
Cap/Sales(5y)5.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-665.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.49%
Revenue growth 3Y-3.96%
Revenue growth 5Y2.24%
Sales Q2Q%-37.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.72%
OCF growth 3YN/A
OCF growth 5YN/A